← Back to Search

Nonsteroidal Anti-inflammatory Drug

Naproxen for Osteoarthritis

N/A
Waitlist Available
Led By Stephen Wright, MD
Research Sponsored by Analgesic Solutions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 weeks
Awards & highlights

Study Summary

This study aims to evaluate various methods of measuring pain relief in subjects who have chronic OA of the knee. After a 1 week of wash-out from existing therapy, subjects will be treated in a blinded fashion for 1 week with either naproxen (3 days at 250 mg twice a day followed by 4 days at 500 mg twice a day) or placebo. After the first week of treatment, subjects will have another week of wash-out followed by a second period of 1 week of the alternate treatment. Subjects will not be allowed to use oral non-steroidal anti-inflammatory drugs (NSAIDs) or other oral analgesics, or topical medications on their target knees during the study. Acetaminophen will be allowed as a rescue medication.

Eligible Conditions
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Efficacy of naproxen vs. placebo
Safety

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: NaproxenActive Control2 Interventions
Group II: PlaceboPlacebo Group2 Interventions

Find a Location

Who is running the clinical trial?

Analgesic SolutionsLead Sponsor
8 Previous Clinical Trials
433 Total Patients Enrolled
2 Trials studying Osteoarthritis
75 Patients Enrolled for Osteoarthritis
Stephen Wright, MDPrincipal InvestigatorAnalgesic Solutions
1 Previous Clinical Trials
98 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025